Bandaram Pharma Packtech Reports Mixed Financial Results Amidst Significant Sales Decline in March 2025
Bandaram Pharma Packtech has released its financial results for the quarter ending March 2025, showing a mixed performance. While Profit After Tax for the nine-month period increased to Rs 0.81 crore, net sales for the quarter declined significantly, and key profit metrics reached their lowest in five quarters.
Bandaram Pharma Packtech, a microcap company in the healthcare services sector, has recently reported its financial results for the quarter ending March 2025. The results indicate a notable shift in the company's evaluation, with the score adjusting to -4 from a previous score of 5 over the last three months.In terms of positive developments, the company has reported an increase in Profit After Tax (PAT) for the nine-month period, reaching Rs 0.81 crore, which surpasses the Rs 0.55 crore recorded in the preceding twelve months. Additionally, Bandaram Pharma has achieved sales that exceed those of the previous twelve-month period.
Conversely, the financial results also highlight challenges faced by the company. Net sales for the quarter stood at Rs 8.49 crore, reflecting a significant year-on-year decline of 36.78%. Furthermore, both Operating Profit (PBDIT) and Profit Before Tax (PBT) have reached their lowest levels in the last five quarters, indicating a negative trend in these areas.
Overall, the financial results for Bandaram Pharma Packtech reveal a complex picture, with both positive and negative factors influencing the company's current standing.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
